title: [Bacterial detection leading to pathogen inactivation].
abstract: Bacterial contamination of blood components remains the highest infectious risk in blood transfusion, the risk is particularly high when it affects platelet concentrates (PC). In France, the residual risk of transfusion reaction due to bacterial contamination of PC has been decreasing slowly since 1994 but for all severity 1 case occurs with about 25,000 distributed PC and one death occurs with 200,000 distributed units. This reduction of the risk may be due to the measures which were implemented during the last 10 years in order to prevent contamination during donation. Improving strategies for reducing the risks of bacterial contamination is one of the priorities of the French National Blood Transfusion Service (l'Etablissement Français du sang - EFS). The main target remains PC. Bacterial detection or pathogens inactivation are now available and are able to reduce (for detection) or prevent (for inactivation) the occurrence of reaction due to bacterial contamination of PC. Up to now, the choice is in favour of bacterial detection. A national study was carried out in seven regional EFS at the end of 2004. It aims at confirming the feasibility of a systematic bacterial screening of PC before their delivery. The first conclusions show that this screening can be implemented with acceptable modifications in term of platelets availability. We can expect in a next future that new pathogens reduction technique and/or new detection systems will be available, certainly more efficient to prevent reaction due to bacterial contamination. Implementation of actual detection methods is probably a temporary solution.
authors.affiliation: Etablissement français du sang Bourgogne-Franche-Comté, Besançon, France. Pascal.morel@efs.sante.fr
authors.forename: P
authors.initials: P
authors.lastname: Morel
authors.forename: M
authors.initials: M
authors.lastname: Deschaseaux
authors.forename: C
authors.initials: C
authors.lastname: Naegelen
authors.forename: L
authors.initials: L
authors.lastname: Bardiaux
authors.forename: M F Leconte
authors.initials: MF
authors.lastname: des Floris
authors.forename: F
authors.initials: F
authors.lastname: Pouthier
mesh_terms: D001431:Bacteriological Techniques; D001769:Blood / Q000382:microbiology*; D016913:Blood Component Transfusion / Q000009:adverse effects / Q000401:mortality / Q000592:standards; D001793:Blood Preservation / Q000379:methods; D001803:Blood Transfusion / Q000401:mortality / Q000592:standards; D017848:Blood-Borne Pathogens / Q000302:isolation & purification* / Q000528:radiation effects; D005602:France; D006801:Humans; D017053:Infection Control / Q000379:methods*; D008403:Mass Screening; D015337:Multicenter Studies as Topic; D012307:Risk Factors; D065227:Transfusion Reaction; D014466:Ultraviolet Rays